VITAMIN SHOPPE, INC. (NYSE:VSI) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02
On April27, 2018, Vitamin Shoppe, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original 8-K”) with the Securities and Exchange Commission reporting that the Company’s Board of Directors (the “Board”) had appointed Mr.MelvinL. Keating, Mr.HimanshuH. Shah and Mr.Sing Wang as directors effective April24, 2018. At the time of the filing of the Original 8-K, Board committee assignments for Messrs. Keating, Shah and Wang had not yet been determined.
Effective June 28, 2018, Mr. Keating and Mr. Wang each became a member of the Audit Committee and Mr. Shah became a member of the Nomination and Governance Committee.
About VITAMIN SHOPPE, INC. (NYSE:VSI)
Vitamin Shoppe, Inc. (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, which includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats; direct, which sells its products directly to consumers through the Internet, primarily at www.vitaminshoppe.com, and manufacturing, which provides custom manufacturing and private labeling of vitamin, mineral and supplement (VMS) products. The Company markets approximately 800 brands, as well as its own brands. The Company operates approximately 760 stores in over 40 states, the District of Columbia, Puerto Rico and Ontario, Canada, primarily located in retail centers and stand-alone locations. The Company also offers homeopathic remedies and weight management products.